Boulding Mark Elliott bought PTCT
April 6, 2026 · Form 4 insider transaction
Boulding Mark Elliott bought 2,265 shares of PTC Therapeutics, Inc. at $39.42 per share, a transaction worth $89.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,265
Price
$39.42
Total value
$89.3K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 6, 2026
Filing dateApril 8, 2026
Shares owned after107,477
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.